Together, these finding confirm the hypothesis that miR-29, when upregulated in the W2KO cells, downregulates ITGB1 by directly binding to its 3′-UTR, which in turn causes the cancer cells to lose their oncogenic properties in vitro and their tumor growth and metastasis promoting potentials in vivo. The gene discussed is ITGB1; the disease is cancer.